U.S. General Merchandise and Department Stores Stock News

Solid Biosciences (SLDB) has just been added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices, an index reshuffle that can influence how some investors view the stock. See our latest analysis for Solid Biosciences. These index additions come after a strong run in Solid Biosciences' share price, with a 30 day share price return of 66.42% and a year to date share price return of 104.59%. The 1 year total shareholder return of 112.79%...

Iran’s renewed push to impose transit tolls in the Strait of Hormuz has reshaped key shipping routes, and Frontline (NYSE:FRO) is at the center of that shift after reporting earnings tied to longer tanker journeys. See our latest analysis for Frontline. At a share price of $37.66, Frontline’s recent momentum is clear, with a 1-day share price return of 2.14%, a 7-day share price return of 8.25%, and an 82.99% year-to-date share price return. The 1-year total shareholder return of 127.34% and...

Ternium earnings outlook and income appeal come into focus Recent analyst actions have sharply raised the consensus earnings outlook for Ternium (NYSE:TX), while its dividend yield now stands well above the broader industry, drawing fresh attention to the stock’s income profile. See our latest analysis for Ternium. Ternium’s share price has eased around 11% over the past month but remains up about 9% year to date, while its 1 year total shareholder return of roughly 39% points to solid longer...

On 27 June 2026, Helix Energy Solutions Group, Inc. (NYSE: HLX) was added to the Russell 2000 Defensive, Growth-Defensive, and Value-Defensive Indexes, boosting its profile among index-linked and institutional investors. This unusual inclusion across multiple Russell 2000 defensive sub-indexes highlights how Helix is now being classified as both growth- and value-oriented within a more defensive universe. Next, we’ll examine how this new Russell 2000 defensive index membership could...

Kimbell Royalty Partners, LP recently filed a shelf registration statement for up to US$101.99 million, covering 6,929,000 common units, giving the partnership flexibility to issue equity in the future. This filing highlights management’s potential interest in future capital raising, which may influence how investors think about funding growth and possible unit dilution. We’ll now explore how this new shelf registration, and the possibility of future common unit issuance, could reshape...

NIP Group (NIPG) is set for a 1-for-30.00003 stock split or significant stock dividend on July 6, 2026, shortly after the resignation of Director and Financial Director Ms. Yanjun Xu. See our latest analysis for NIP Group. At a latest share price of $7.79, NIP Group has seen its 30 day share price return fall 33.11% and its 1 year total shareholder return decline 87.58%. This suggests momentum has weakened ahead of the announced stock split and recent board change. If this kind of volatility...

In late June 2026, Aflac Incorporated filed an omnibus shelf registration covering common stock, debt securities, warrants, subscription rights, purchase contracts, and purchase units, expanding its flexibility to raise capital across multiple instruments. Coming soon after a cybersecurity breach at its Japanese subsidiary, this broad shelf registration highlights how Aflac is preserving funding options while managing heightened operational and reputational risk. We’ll now examine how the...

On 27 June 2026, Vishay Precision Group, Inc. (NYSE: VPG) was added to multiple Russell indexes, including the Russell 3000 Growth, Russell 2000 Growth, and Russell 2500 Growth benchmarks. This broad index inclusion increases VPG’s visibility to passive and benchmark-driven investors, potentially influencing trading volumes, ownership mix, and how the market evaluates its growth profile. We’ll now examine how VPG’s broad inclusion across Russell growth indexes may reshape its existing...

Avalo Therapeutics was recently added to multiple Russell indices and appointed veteran biopharma executive Ron Philip to its board, moves that follow positive Phase 2 data for its lead IL‑1β antibody abdakibart in hidradenitis suppurativa and preparation for investor meetings at the Leerink Partners Therapeutics Forum. Together, the index inclusions, strengthened governance, and focus on IL‑1β‑targeted therapies highlight how a once‑smaller biotech is gaining broader institutional...

Tariff shocks are back on the table, and this time the proposals reach across 60 economies, from key allies to major trade partners like China and India. For US transportation and logistics stocks, higher trade barriers can reshuffle supply chains, alter freight volumes, and change where value is created. That can create fresh pressure for some companies and new openings for others. This article looks at 3 stocks from a US Transportation and Logistics Companies screener that appear positioned...

Dish Wireless has filed for Chapter 11 bankruptcy, reducing a direct rival in the U.S. wireless market. T-Mobile US plans to shut down its legacy 2G GSM network after 35 years of operation. These developments could affect T-Mobile's pricing power, customer mix, and network modernization timeline. T-Mobile US (NasdaqGS:TMUS) is seeing its competitive position reshaped just as its stock trades at $181.79. The company has posted a gain of 4.5% over the past week and 2.1% over the past month,...

In June 2026, J&J Snack Foods Corp. was moved out of several Russell growth benchmarks and added to multiple Russell value-oriented indices, including the Russell 2000 Value, Russell 2500 Value, and Russell 3000 Value benchmarks. This shift from growth to value classifications changes how index funds and style-focused investors may view J&J Snack Foods within their portfolios. Next, we’ll examine how J&J Snack Foods’ reclassification into value-focused Russell indices could influence its...

Shopify’s valuation picture has become more finely balanced, with the stock up 94.1% over the past three years, while the Discounted Cash Flow (DCF) intrinsic value estimate now lines up close to the current share price and earnings multiples screen as expensive. Shopify’s 94.1% three year return signals that a large part of the story is already reflected in the share price, so fresh upside may need stronger fundamentals to support it. Expectations around continued revenue growth supported...

Amer Sports, Inc. (NYSE:AS) was recently added to multiple Russell growth indices, including the Russell Midcap Growth, Russell 1000 Growth, Russell 2500 Growth, Russell Small Cap Comp Growth, Russell 3000E Growth, and Russell 3000 Growth benchmarks. This broad inclusion across the Russell growth family could increase index-linked ownership and visibility for Amer Sports among growth-focused institutional investors. Now we’ll explore how Amer Sports’ broad inclusion in Russell growth indices...

La-Z-Boy stock has delivered a 43.7% return over the past three years, yet current valuation work suggests the shares may still trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach. Over the last three years, La-Z-Boy has returned 43.7%, which puts recent share performance firmly in positive territory but not at levels that clearly rule out further upside if the valuation case holds. For La-Z-Boy, the ability to keep converting earnings into steady cash flow...

In late June 2026, Recursion Pharmaceuticals, Inc. was added to several Russell value and small-cap benchmarks, widening its footprint across key US equity indices and increasing its visibility to institutional and index-tracking investors. This broader index inclusion, combined with growing attention on its AI-native drug discovery platform and advancing clinical pipeline, is subtly reshaping how the market weighs Recursion’s mix of high innovation, high costs, and partnership-driven...

Hamilton Lane stock has had a tough year, with a steep decline in the share price set against valuation checks that now lean toward the shares looking cheap on several measures. With the company still active in raising and deploying capital, investors are weighing whether the current level reflects a reset in expectations or a potential mispricing. Over the past 12 months, Hamilton Lane shares have fallen 42.4%, which naturally raises the question of whether sentiment has moved further than...

Tariffs back in the headlines can rattle import heavy retailers, but they can also shine a light on companies that look better prepared for higher trade frictions. With potential 10% to 12.5% duties on goods from 60 countries and renewed global tariffs on the table, some large U.S. consumer retailers with strong North American focus and healthier balance sheets may be positioned to handle higher costs more effectively than peers. This article walks through 3 stocks from a U.S. Import...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In such an environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on future growth prospects.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings projected to grow by 18% annually in the coming years. In this environment, identifying growth companies with strong insider ownership can be a strategic approach as it often indicates confidence from those closest to the business and potential alignment with shareholder interests.

In the last week, the United States market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. Investing in penny stocks—though often considered a niche area—can still present growth opportunities, especially when these stocks are supported by strong financial health. Here, we explore several intriguing penny stocks that stand out for their financial strength and potential for long-term growth.

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals (NasdaqGS:CRNX) in an all cash deal valued at about US$10b. The boards of both companies approved the transaction unanimously. The deal is expected to close in Q3 2026, subject to regulatory and Crinetics shareholder approvals. Crinetics Pharmaceuticals focuses on endocrine diseases, an area where larger drug makers have been looking to expand their presence. Vertex is set to add Crinetics' pipeline and clinical expertise to...

In late June 2026, Core & Main, Inc. (NYSE:CNM) was removed from multiple Russell growth benchmarks, including the Russell 1000 Growth, 3000E Growth, 2500 Growth, Midcap Growth, and Small Cap Comp Growth indices. This broad index removal could reshape the company’s investor base and trading patterns as funds tracking these benchmarks adjust their Core & Main holdings. We’ll now explore how Core & Main’s removal from several Russell growth indices may affect its previously outlined investment...

MillerKnoll, Inc. recently reported past fourth-quarter and full-year 2026 results showing higher sales of US$1,004.2 million and US$3.84 billion respectively, alongside a move from losses to net income and positive earnings per share from continuing operations. The company also issued fiscal 2027 guidance calling for US$928 million–US$968 million in first-quarter sales and US$3.93 billion–US$4.13 billion for the full year, signaling expectations for higher revenue with gross margins...